
Biotech

Broadband

B2B Internet

Europe 2001

Internet

Internet Architecture

Internet Infrastructure

Market 2000+

Oil Services

Pharmaceutical

Regional Bank

Retail

Semiconductor

Software

Telecom

Utilities

Wireless

ImmunoGen Inc (NASDAQ GM:IMGN)

9:55 AM ET

most recent headlines

more headlines:

THURSDAY, FEBRUARY 04, 2010
10:23 AM	BiomedReports: News and FDA Updates for ImmunoGen (Nasdaq:IMGN), ImmunoGen (Nasdaq:IMGN), MedLink (OTC:MLKNA) - M2

WEDNESDAY, FEBRUARY 03, 2010
10:30 AM	ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 25, 2010 - BusinessWire

TUESDAY, FEBRUARY 02, 2010
6:30 AM	ImmunoGen, Inc. Announces Webcast of Presentation at the 12th Annual BIO CEO & Investor Conference - BusinessWire

FRIDAY, JANUARY 29, 2010
7:56 AM	ImmunoGen Inc reports increased Q2 loss - M2

THURSDAY, JANUARY 28, 2010
4:01 PM	ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2010 Financial Results - BusinessWire

MONDAY, JANUARY 25, 2010
2:04 PM	Brean Murray, Carret & Co. Announces 2010 Healthcare 1x1 Conference - PR Newswire

THURSDAY, JANUARY 21, 2010
6:30 AM	ImmunoGen, Inc. Announces Conference Call to Discuss Its Second Quarter Fiscal Year 2010 Financial Results - BusinessWire

WEDNESDAY, JANUARY 06, 2010
9:25 AM	ImmunoGen, Inc. Announces Webcast of Presentation at the 28th Annual J.P. Morgan Healthcare Conference - BusinessWire

THURSDAY, DECEMBER 17, 2009
4:01 PM	ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality - BusinessWire

SATURDAY, DECEMBER 12, 2009
8:00 AM	ImmunoGen, Inc. Announces Positive Trastuzumab-DM1 Clinical Data Reported at the San Antonio Breast Cancer Symposium - BusinessWire

Quotes delayed at least 15 minutes. Market data provided by Interactive Data.
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

The information on HOLDRS^SM contained in this Internet site is solely for informational purposes and does not constitute either an offer to sell or the solicitation of an offer to buy HOLDRS. This information on HOLDRS is not, and is not intended to be, a complete discussion of all material information you should know about HOLDRS. If you are considering whether to purchase a HOLDRS security, you should carefully read the relevant prospectus prior to making a purchase. You should not rely on the information contained in this Internet site. Please view Terms of Use and Legal Notices for additional important legal information and the terms and conditions governing your use of this site.